au.\*:("WILLMAN, C. L")
Results 1 to 25 of 62
Selection :
Immunophenotyping and cytogenetics in older adults with acute myeloid leukemia : significance of expression of the multidrug resistance gene-1 (MDR1)WILLMAN, C. L.Leukemia. 1996, Vol 10, pp S33-S35, issn 0887-6924, SUP1Conference Paper
Targeted AML therapy : new biologic paradigms and therapeutic opportunities : Advances and controversies in the therapy of acute myelogenous leukemiaWILLMAN, C. L.Leukemia. 2001, Vol 15, Num 4, pp 690-694, issn 0887-6924Conference Paper
Detection of clonal histiocytes in Langerhans cell histiocytosis : biology and clinical significanceWILLMAN, C. L.British journal of cancer. 1994, Vol 70, pp S29-S33, issn 0007-0920, SUP23Article
Molecular evaluation of acute myeloid leukemiasWILLMAN, C. L.Seminars in hematology. 1999, Vol 36, Num 4, pp 390-400, issn 0037-1963Article
Molecular genetic features of myelodysplastic syndromes (MDS)WILLMAN, C. L.Leukemia. 1998, Vol 12, pp S2-S6, issn 0887-6924, SUP1Conference Paper
Molecular genetic approaches for the diagnosis of clonality in lymphoid neoplasmsWILLMAN, C. L; GRIFFITH, B. B; WHITTAKER, M et al.Clinics in laboratory medicine. 1990, Vol 10, Num 1, pp 119-149, issn 0272-2712Article
Oncogenes, suppressor genes, and carcinogenesisWILLMAN, C. L; FENOGLIO-PREISER, C. M.Human pathology. 1987, Vol 18, Num 9, pp 895-902, issn 0046-8177Article
The function of src family tyrosine kinases in hematopoietic cellsYIN XU; POTTER, J. W; WILLMAN, C. L et al.Leukemia research. 1996, Vol 20, Num 3, pp 229-234, issn 0145-2126Article
The molecular biology of acute myeloid leukemia : proto-oncogene expression and function in normal and neoplastic myeloid cellsWILLMAN, C. L; WHITTAKER, M. H.Clinics in laboratory medicine. 1990, Vol 10, Num 4, pp 769-796, issn 0272-2712Article
Acute myelogenous leukemia and aging: Clinical interactionsLANCET, J. E; WILLMAN, C. L; BENNETT, J. M et al.Hematology/oncology clinics of North America. 2000, Vol 14, Num 1, issn 0889-8588, xi,251-267 [18 p.]Article
A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia : A southwest oncology group study (9031)GODWIN, J. E; KOPECKY, K. J; HEAD, D. R et al.Blood. 1998, Vol 91, Num 10, pp 3607-3615, issn 0006-4971Article
Characterization and use of an antibody detecting the CBFβ-SMMHC fusion protein in inv(16)/t(16;16)-associated acute myeloid leukemiasVISWANATHA, D. S; CHEN, I.-M; PU PAUL LIU et al.Blood. 1998, Vol 91, Num 6, pp 1882-1890, issn 0006-4971Article
Methods to detect P-glycoprotein-associated multidrug resistance in patients tumors : Consensus recommendationsBECK, W. T; GROGAN, T. M; BROPHY, N. A et al.Cancer research (Baltimore). 1996, Vol 56, Num 13, pp 3010-3020, issn 0008-5472Article
Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry : identification of discordant MDR-/efflux+ and MDR1/efflux- casesLEITH, C. P; I-MING CHEN; KOPECKY, K. J et al.Blood. 1995, Vol 86, Num 6, pp 2329-2342, issn 0006-4971Article
Cytogenetically aberant cells in the stem cell compartment (CD34+lin-) in acute myeloid leukemiaMEHROTRA, B; GEORGE, T. I; KAVANAU, K et al.Blood. 1995, Vol 86, Num 3, pp 1139-1147, issn 0006-4971Article
GSI-I (Z-LLNIe-CHO) inhibits γ-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemiaMENG, X; MATLAWSKA-WASOWSKA, K; WINTER, S. S et al.Leukemia. 2011, Vol 25, Num 7, pp 1135-1146, issn 0887-6924, 12 p.Article
A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignanciesSLOVAK, M. L; GUNDACKER, H; WILLMAN, C. L et al.Leukemia. 2006, Vol 20, Num 7, pp 1295-1297, issn 0887-6924, 3 p.Article
Estrogen receptor methylation is associated with improved survival in adult acute myeloid leukemiaQING LI; KOPECKY, K. J; MOHAN, A et al.Clinical cancer research. 1999, Vol 5, Num 5, pp 1077-1084, issn 1078-0432Article
Lack of IRF-1 expression in acute promyelocytic leukemia and in a subset of acute myeloid leukemias with del(5)(q31)GREEN, W. B; SLOVAK, M. L; CHEN, I.-M et al.Leukemia. 1999, Vol 13, Num 12, pp 1960-1971, issn 0887-6924Article
HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalitiesHUNGER, S. P; TKACHUK, D. C; AMYLON, M. D et al.Blood. 1993, Vol 81, Num 12, pp 3197-3203, issn 0006-4971Article
Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosme band 3q26MORISHITA, K; PARGANAS, E; WILLMAN, C. L et al.Proceedings of the National Academy of Sciences of the United States of America. 1992, Vol 89, Num 9, pp 3937-3941, issn 0027-8424Article
A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and the mdr modulator PSC 833: a Southwest Oncology Group study 9617CHAUNCEY, T. R; RANKIN, C; KRAUT, E. H et al.Leukemia research. 2000, Vol 24, Num 7, pp 567-574, issn 0145-2126Article
Trisomy 6 as a primary karyotypic aberration in hematologic disordersMOHAMED, A. N; VARTERASIAN, M. L; DOBIN, S. M et al.Cancer genetics and cytogenetics. 1998, Vol 106, Num 2, pp 152-155, issn 0165-4608Article
Multidrug resistance-1 (MDR1) expression and functional dye/drug efflux is highly correlated with the (8;21) chromosomal translocation in pediatric acute myeloid leukemiaPEARSON, L; LEITH, C. P; DUNCAN, M. H et al.Leukemia. 1996, Vol 10, Num 8, pp 1274-1282, issn 0887-6924Article
Amplification of the E2F1 transcription factor gene in the HEL erythroleukemia cell lineSAITO, M; HELIN, K; VALENTINE, M. B et al.Genomics (San Diego, Calif.). 1995, Vol 25, Num 1, pp 130-138, issn 0888-7543Article